查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1488255

動態血壓監測設備市場 - 按設備類型（產品 [數位、無液、水銀]、配件）、操作（自動、半自動、手動）、配置（攜帶式、桌上型、落地式、壁掛式） - 全球預測，2024 年- 2032

Ambulatory Blood Pressure Monitoring Devices Market - By Device Type (Products [Digital, Aneroid, Mercury], Accessories), Operation (Automatic, Semi-automatic, Manual), Configuration (Portable, Desk Mounted, Floor, Wall) - Global Forecast, 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

在全球高血壓和相關心血管疾病盛行率不斷上升的推動下，動態血壓監測設備市場規模預計在 2024 年至 2032 年間將以 8.5% 的複合年成長率成長。據世界衛生組織稱，全世界三分之一的成年人患有高血壓。動態血壓監測 (ABPM) 裝置可在 24 小時內連續、非侵入性地監測血壓，為醫療保健專業人員提供有關患者血壓波動的寶貴見解。對預防性醫療保健和早期疾病檢測的日益重視也推動了產品的採用。

動態血壓監測設備的技術不斷進步，為開發具有更高準確性和舒適度的緊湊型穿戴式裝置鋪平了道路。醫療保健支出的增加，加上政府和醫療保健組織促進遠距患者監護設備使用的措施將決定市場的成長。

動態血壓監測設備產業根據設備類型、操作、配置和地區進行分類。

在預測期內，配件設備類型細分市場的市場規模將產生可觀的收入，複合年成長率為 8.2%。擴大採用動態血壓監測設備來長期監測高血壓，因此需要相容的配件來確保準確可靠的測量。袖帶、轉接器和軟體解決方案等配件也有助於增強功能和產品可用性，從而推動產品需求。

手動操作領域的動態血壓監測設備市場預計2024 年至2032 年間複合年成長率為7.9%。專業人員的青睞。手動血壓監測儀也比自動血壓監測儀更具成本效益，使其可供更廣泛的醫療機構和患者使用，特別是在資源有限的環境中。

由於高血壓和心血管疾病盛行率不斷上升，亞太地區動態血壓監測設備市場預計在 202-2032 年期間複合年成長率為 9.4%。快速的技術進步，例如緊湊且方便用戶使用的 ABPM 設備的開發，鼓勵了醫療保健專業人員和患者的採用。醫療保健支出的增加、人們對定期血壓監測重要性的認知不斷提高以及政府為促進預防性醫療保健措施而採取的有利舉措也將刺激該區域市場的成長。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 高血壓和心血管疾病盛行率增加
      • 越來越重視預防保健
      • 技術進步
    • 產業陷阱與挑戰
      • 血壓監測設備成本高昂
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 2023 年定價分析
  • 波特的分析
  • PESTEL分析
  • 報銷場景
  • 未來市場趨勢
  • 缺口分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按設備類型，2018 年 - 2032 年

  • 主要趨勢
  • 產品
    • 數位血壓監測儀
      • 上臂監視器
      • 腕式監視器
      • 手指監視器
    • 無液體血壓監測儀
    • Mercury 血壓監測儀
  • 配件

第 6 章：市場估計與預測：按營運分類，2018 年 - 2032 年

  • 主要趨勢
  • 自動的
  • 半自動
  • 手動的

第 7 章：市場估計與預測：按配置，2018 - 2032 年

  • 主要趨勢
  • 便攜的
  • 桌面安裝式
  • 落地式
  • 壁掛式

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 9 章：公司簡介

  • A&D Company, Limited
  • American Diagnostic Corporation
  • Beurer GmbH
  • Contec
  • Dr. Morepen
  • ForaCare, Inc.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • iHealth Labs Inc
  • Koninklijke Philips N.V.
  • Microlife Corporation
  • OMRON Corporation
  • Rossmax International Ltd.
簡介目錄
Product Code: 8573

Ambulatory blood pressure monitoring devices market size is anticipated to grow at 8.5% CAGR between 2024 and 2032, driven by the rising prevalence of hypertension and related cardiovascular diseases worldwide. As per who, hypertension affects 1 in 3 adults worldwide. Ambulatory blood pressure monitoring (ABPM) devices offer continuous and non-invasive monitoring of blood pressure over a 24-hour period for providing healthcare professionals with valuable insights into patient blood pressure fluctuations. The growing emphasis on preventive healthcare and early disease detection is also driving the product adoption.

Growing technological advancements in ambulatory blood pressure monitoring devices have made way for the development of compact and wearable devices with enhanced accuracy and comfort. Rising healthcare expenditure, coupled with initiatives by governments and healthcare organizations to promote the use of remote patient monitoring devices will define the market growth.

The ambulatory blood pressure monitoring devices industry is classified based on device type, operation, configuration, and region.

The market size from the accessories device type segment will generate notable revenue at 8.2% CAGR during the forecast period. The increasing adoption of ambulatory blood pressure monitoring devices for long-term monitoring of hypertension is necessitating the need for compatible accessories to ensure accurate and reliable measurements. Accessories, such as cuffs, adapters, and software solutions also help in enhancing the functionality and product usability, thereby driving the product demand.

Ambulatory blood pressure monitoring devices market from the manual operation segment is anticipated to witness 7.9% CAGR between 2024 and 2032. Despite the emergence of automated monitoring devices, manual ambulatory blood pressure monitors continue to be preferred by healthcare professionals for their accuracy and reliability in measuring BP. Manual BP monitors are also more cost-effective than automated alternatives, making them accessible to a wider range of healthcare facilities and patients, especially in resource-constrained settings.

Asia Pacific ambulatory blood pressure monitoring devices market is projected to exhibit 9.4% CAGR during 202-2032, attributed to the rising prevalence of hypertension and cardiovascular diseases. Rapid technological advancements, such as the development of compact and user-friendly ABPM devices, have encouraged their adoption among both healthcare professionals and patients. The increasing healthcare expenditure, growing awareness about the importance of regular blood pressure monitoring, and favorable government initiatives for promoting preventive healthcare measures will also stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of hypertension and cardiovascular diseases
      • 3.2.1.2 Growing focus on preventive healthcare
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with blood pressure monitoring devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Pricing analysis, 2023
  • 3.7 Porter's analysis
    • 3.7.1 Supplier power
    • 3.7.2 Buyer power
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Industry rivalry
  • 3.8 PESTEL analysis
  • 3.9 Reimbursement scenario
  • 3.10 Future market trends
  • 3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Products
    • 5.2.1 Digital BP monitors
      • 5.2.1.1 Upper arm monitors
      • 5.2.1.2 Wrist monitors
      • 5.2.1.3 Finger monitors
    • 5.2.2 Aneroid BP monitors
    • 5.2.3 Mercury BP monitors
  • 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Operation, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Automatic
  • 6.3 Semi-automatic
  • 6.4 Manual

Chapter 7 Market Estimates and Forecast, By Configuration, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Portable
  • 7.3 Desk mounted
  • 7.4 Floor standing
  • 7.5 Wall mounted

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 A&D Company, Limited
  • 9.2 American Diagnostic Corporation
  • 9.3 Beurer GmbH
  • 9.4 Contec
  • 9.5 Dr. Morepen
  • 9.6 ForaCare, Inc.
  • 9.7 GE HealthCare Technologies Inc.
  • 9.8 Hill-Rom Holdings, Inc.
  • 9.9 iHealth Labs Inc
  • 9.10 Koninklijke Philips N.V.
  • 9.11 Microlife Corporation
  • 9.12 OMRON Corporation
  • 9.13 Rossmax International Ltd.